Home Contact Sitemap

PedAM

Pediatric Disease Annotations & Medicines




Disease angina pectoris
Phenotype C0022116|ischaemia
Sentences 3
PubMedID- 22328891 The 14-day therapy with a double dose of rabeprazole (open-label trial) [56] or omeprazole (randomized, placebo-controlled cross-over trial) [57] may lead to a decrease in the number of total chest pain episodes and in some electrocardiographic signs of myocardial ischaemia in patients with stable angina pectoris and cad.
PubMedID- 20542554 If such an effect also occurs in man, this class of inhibitors could become a new treatment for ischaemia in patients with angina pectoris.
PubMedID- 22371748 The results of our investigations showed that 14-day therapy with a double dose of rabeprazole (open-label trial) [3] or omeprazole (randomized, placebo controlled cross-over trial) [7] leads to a decrease in the number of total chest pain episodes and in some electrocardiographic signs of myocardial ischaemia in patients with stable angina pectoris and cad.

Page: 1